Literature DB >> 15329415

Biochemical evidence for the association of fragile X mental retardation protein with brain polyribosomal ribonucleoparticles.

Edouard W Khandjian1, Marc-Etienne Huot, Sandra Tremblay, Laetitia Davidovic, Rachid Mazroui, Barbara Bardoni.   

Abstract

Fragile X syndrome is caused by the absence of the fragile X mental retardation protein (FMRP). This RNA-binding protein is widely expressed in human and mouse tissues, and it is particularly abundant in the brain because of its high expression in neurons, where it localizes in the cell body and in granules throughout dendrites. Although FMRP is thought to regulate trafficking of repressed mRNA complexes and to influence local protein synthesis in synapses, it is not known whether it has additional functions in the control of translation in the cell body. Here, we have used recently developed approaches to investigate whether FMRP is associated with the translation apparatus. We demonstrate that, in the brain, FMRP is present in actively translating polyribosomes, and we show that this association is acutely sensitive to the type of detergent required to release polyribosomes from membranous structures. In addition, proteomic analyses of purified brain polyribosomes reveal the presence of several RNA-binding proteins that, similarly to FMRP, have been previously localized in neuronal granules. Our findings highlight the complex roles of FMRP both in actively translating polyribosomes and in repressed trafficking ribonucleoparticle granules.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15329415      PMCID: PMC516571          DOI: 10.1073/pnas.0405398101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  61 in total

Review 1.  mRNA localization: message on the move.

Authors:  R P Jansen
Journal:  Nat Rev Mol Cell Biol       Date:  2001-04       Impact factor: 94.444

Review 2.  Molecular insights into mRNA transport and local translation in the mammalian nervous system.

Authors:  M A Kiebler; L DesGroseillers
Journal:  Neuron       Date:  2000-01       Impact factor: 17.173

Review 3.  Local protein synthesis and its role in synapse-specific plasticity.

Authors:  K C Martin; M Barad; E R Kandel
Journal:  Curr Opin Neurobiol       Date:  2000-10       Impact factor: 6.627

4.  Evidence that fragile X mental retardation protein is a negative regulator of translation.

Authors:  B Laggerbauer; D Ostareck; E M Keidel; A Ostareck-Lederer; U Fischer
Journal:  Hum Mol Genet       Date:  2001-02-15       Impact factor: 6.150

Review 5.  eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation.

Authors:  A C Gingras; B Raught; N Sonenberg
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

6.  [40 S ribonucleoprotein particles in rat liver nuclei].

Authors:  Y Moulé; J Chauveau
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

7.  Quantitative isolation and properties of nearly homogeneous populations of undegraded free and bound polysomes from rat brain.

Authors:  J C Ramsey; W J Steele
Journal:  J Neurochem       Date:  1977-03       Impact factor: 5.372

8.  The isolation of polysomes from rat liver. Contamination of polysomes by ribonucleoprotein of nuclear origin.

Authors:  S Olsnes
Journal:  Biochim Biophys Acta       Date:  1970-07-16

9.  Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination.

Authors:  S A Irwin; B Patel; M Idupulapati; J B Harris; R A Crisostomo; B P Larsen; F Kooy; P J Willems; P Cras; P B Kozlowski; R A Swain; I J Weiler; W T Greenough
Journal:  Am J Med Genet       Date:  2001-01-15

10.  FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association.

Authors:  Y Feng; D Absher; D E Eberhart; V Brown; H E Malter; S T Warren
Journal:  Mol Cell       Date:  1997-12       Impact factor: 17.970

View more
  84 in total

1.  Unfolding neurodevelopmental disorders: found in translation.

Authors:  Jonathan T Ting; Guoping Feng
Journal:  Nat Med       Date:  2011-11-02       Impact factor: 53.440

Review 2.  Cytoplasmic RNA-binding proteins and the control of complex brain function.

Authors:  Jennifer C Darnell; Joel D Richter
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-08-01       Impact factor: 10.005

3.  Molecular and genetic analysis of the Drosophila model of fragile X syndrome.

Authors:  Charles R Tessier; Kendal Broadie
Journal:  Results Probl Cell Differ       Date:  2012

4.  Fragile X syndrome: (What's) lost in translation?

Authors:  Kevin Miyashiro; James Eberwine
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-06       Impact factor: 11.205

Review 5.  RNA transport and local control of translation.

Authors:  Stefan Kindler; Huidong Wang; Dietmar Richter; Henri Tiedge
Journal:  Annu Rev Cell Dev Biol       Date:  2005       Impact factor: 13.827

6.  Cold stress-induced protein Rbm3 binds 60S ribosomal subunits, alters microRNA levels, and enhances global protein synthesis.

Authors:  John Dresios; Armaz Aschrafi; Geoffrey C Owens; Peter W Vanderklish; Gerald M Edelman; Vincent P Mauro
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-31       Impact factor: 11.205

Review 7.  The fragile X mental retardation protein in circadian rhythmicity and memory consolidation.

Authors:  Cheryl L Gatto; Kendal Broadie
Journal:  Mol Neurobiol       Date:  2009-02-12       Impact factor: 5.590

Review 8.  The state of synapses in fragile X syndrome.

Authors:  Brad E Pfeiffer; Kimberly M Huber
Journal:  Neuroscientist       Date:  2009-03-26       Impact factor: 7.519

9.  Drosophila fragile X mental retardation protein and metabotropic glutamate receptor A convergently regulate the synaptic ratio of ionotropic glutamate receptor subclasses.

Authors:  Luyuan Pan; Kendal S Broadie
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

Review 10.  The translation of translational control by FMRP: therapeutic targets for FXS.

Authors:  Jennifer C Darnell; Eric Klann
Journal:  Nat Neurosci       Date:  2013-04-14       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.